跳至主要内容
临床试验/NCT00728884
NCT00728884已完成不适用

Observational Study of Certain Prevail Implant System in Maxillary and Mandibular Regions

ZimVie2 个研究点 分布在 1 个国家目标入组 161 人开始时间: 2005年9月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
ZimVie
入组人数
161
试验地点
2
主要终点
Osseous Integration

研究概览

简要总结

This observational, prospective clinical study evaluates the performance of the Certain Prevail implant system to show potential crestal bone and soft tissue preservation following the crestal bone. It will also evaluate implant performance.

Study (null) hypothesis: The preservation of crestal bone for the Certain Prevail implants will be the same as that for standard non-platform switched implants from contemporaneous studies (historical controls).

详细描述

This is a prospective, observational study of patients with partial or complete edentulism treated with the Certain Prevail dental implants. Restorations will consist of single tooth replacements, short and long fixed bridges, and overdentures and full dentures. All implants are placed using a single stage approach and temporalization occurring after two months of healing (early loading). Each center will strive to enroll a total of 20 patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients of either sex and any race greater than 18 years of age
  • patients for whom a decision has already been made to use dental implants for treating an existing dental condition specifically:
  • dental implants restored as single tooth replacements, short and long fixed bridges, overdenture, or fixed full denture.
  • a temporary healing abutment will be placed on implant during implant placement surgery (single stage procedure).
  • patients must be physically able to tolerate conventional surgical and restorative procedures
  • patients must agree to be evaluated for each study visit, especially the yearly follow-up visit

排除标准

  • patients with active infection or severe inflammation in the areas intended for implant placement
  • patients with a >10 cigarette per day smoking habit
  • patients with uncontrolled diabetes mellitus
  • patients with metabolic bone disease
  • patients who have had treatment with therapeutic radiation to the head within the past 12 months
  • patients in need of allogenic bone grafting at the site of the intended study implant for augmentation purposes. Grafting for treatment of dehiscence or fenestration must have occurred at least 8 weeks prior to implant placement surgery
  • patients who are pregnant at the screening visit
  • patients with evidence of severe para-functional habits such as bruxing or clenching
  • patients with less than 6 weeks of healing time post tooth extraction at the intended treatment site

结局指标

主要结局

Osseous Integration

时间窗: one year

Osseous Integration

时间窗: 2 years

次要结局

  • Crestal Bone Resorption(four years)

研究者

发起方
ZimVie
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验